Injectable Cephalosporin (ceftiofur) with bactericidal properties related to the inhibition of bacteria cell wall synthesis and active against Gram (+) and Gram (-), indicated for the treatment of bacterial respiratory disease in which Pasteurella multocida, Actinobacillus pleuropneumoniae and Streptococcus suis are involved.
From one country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the CEVA Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons.